Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Xeris Biopharma Holdings (XERS) Interest Coverage Ratio (2020 - 2025)

Xeris Biopharma Holdings' Interest Coverage Ratio history spans 6 years, with the latest figure at 2.34 for Q4 2025.

  • For the quarter ending Q4 2025, Interest Coverage Ratio rose 975.49% year-over-year to 2.34, compared with a TTM value of 0.85 through Dec 2025, up 177.57%, and an annual FY2025 reading of 0.86, up 177.55% over the prior year.
  • Interest Coverage Ratio for Q4 2025 was 2.34 at Xeris Biopharma Holdings, up from 0.92 in the prior quarter.
  • The five-year high for Interest Coverage Ratio was 2.34 in Q4 2025, with the low at 26.88 in Q4 2021.
  • Average Interest Coverage Ratio over 5 years is 4.69, with a median of 2.08 recorded in 2023.
  • Year-over-year, Interest Coverage Ratio plummeted 543.47% in 2021 and then soared 975.49% in 2025.
  • Tracing XERS's Interest Coverage Ratio over 5 years: stood at 26.88 in 2021, then surged by 87.08% to 3.47 in 2022, then skyrocketed by 59.58% to 1.4 in 2023, then surged by 115.49% to 0.22 in 2024, then soared by 975.49% to 2.34 in 2025.
  • Per Business Quant, the three most recent readings for XERS's Interest Coverage Ratio are 2.34 (Q4 2025), 0.92 (Q3 2025), and 0.61 (Q2 2025).